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Research
AbstrACt
Objective To evaluate the association between growth 
trajectories from birth to adolescence and cardiovascular 
risk marker levels at age 18 years in a population-based 
cohort. In order to disentangle the effect of weight gain 
from that of height gain, growth was analysed using 
conditional weight relative to linear growth (CWh) and 
conditional length/height (CH).
Design Prospective study.
setting 1993 Pelotas birth cohort, Southern Brazil.
Participants Individuals who have been followed up from 
birth to adolescence (at birth, 1, 4, 11, 15 and 18 years).
Primary outcome measures C-reactive protein (CRP), 
total cholesterol (TC), LDL cholesterol (LDL-C), HDL-
cholesterol (HDL-C), triglycerides (TGL), systolic and 
diastolic blood pressure (SBP and DBP), body mass index 
(BMI) and waist circumference (WC).
results In both sexes, greater CWh at 1 year was 
positively associated with BMI and WC, whereas greater 
CWh at most age periods in childhood and adolescence 
predicted higher CRP, TC, LDL-C, TGL, SBP, DBP, BMI and 
WC levels, as well as lower HDL-C level. Higher CH during 
infancy and childhood was positively related with SBP in 
boys and girls, and with BMI and WC only in boys.
Conclusion Our study shows that rapid weight gain 
from 1 year onwards is positively associated with several 
markers of cardiovascular risk at 18 years. Overall, 
our results for the first year of life add evidence to the 
‘first 1000 days initiative’ suggesting that prevention of 
excessive weight gain in childhood might be important in 
reducing subsequent cardiovascular risk.
IntrODuCtIOn
Metabolic and cardiovascular diseases are 
important public health problems that cause 
enormous costs in terms of human and 
economic resources and are responsible for 
high rates of morbidity and mortality in most 
regions of the world.1 
Growth trajectories throughout life course, 
including the fetal period, may have effects 
on the cardiovascular risk profile later in life.2 
It is well established in the literature that low 
birth weight (a marker of fetal growth restric-
tion) is a risk factor for type 2 diabetes,3 insulin 
resistance4 and cardiovascular diseases.5 6 
However, the critical age interval (first year 
of life or middle childhood) for accelerated 
growth (weight and height changes) that 
leads to the development of chronic condi-
tions remains controversial.5 7 8 Evidence 
suggests that accelerated weight gain during 
infancy is associated with an adverse meta-
bolic risk profile in adulthood.7 9 10 In addi-
tion, it has been found that rapid weight gain 
increases the risk of metabolic disturbances 
when it occurs during childhood, as a result 
of a more rapid development of body fat 
mass.11 The definition of this critical period is 
crucial to inform health policies.
Studies on growth trajectories throughout 
life course and adult outcomes have exam-
ined weight gain without any distinction 
between the weight gain relative to height 
and linear growth. Dissimilar consequences 
of these measures have been found,12 13 which 
are relevant for healthcare policy makers 
when developing programmes for cardiomet-
abolic risk prevention. In this study we 
aimed to assess the associations between size 
at birth (weight and length), conditional 
strengths and limitations of this study
 ► Population-based sample birth cohort; data collected 
prospectively over 18 years since birth with high 
follow-up rates.
 ► Availability of several anthropometric and biological 
markers of cardiovascular risk.
 ► Use of conditional growth to examine highly 
correlated measurements, and assessment of the 
separate contributions of linear growth and relative 
weight gain.
 ► Use of subsample in one of the follow-ups. Multiple 
hypothesis testing leads to increased type I error.
 ► Lack of anthropometric data at 2 years is a limitation, 
since there is evidence suggesting that the hazards 
of rapid weight gain appear particularly after the first 
2 years of life.
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relative weight (CWh) and conditional length/height 
(CH) at ages 1, 4, 11, 15 and 18 years and cardiovascular 
risk markers (C-reactive protein (CRP), lipid profile, 
body mass index (BMI) and waist circumference (WC) 
in adolescents aged 18 years who are participants in the 
1993 Pelotas birth cohort study.
MethODs
The city of Pelotas, a medium-sized city with nearly 
330 000 inhabitants, is located in southern Brazil. In 1993, 
all mothers who delivered a newborn in any of the five 
hospitals of the city and who resided in the urban area 
were invited to participate in a birth cohort study (99% 
of all births). Data were collected on 5249 live births and 
only 16 individuals refused to participate. The cohort 
participants have been followed up at different time 
points thereafter. All visits were carried out by trained 
interviewers and fieldwork team members. Further details 
of the methodology have been published previously.14
This study included information from six follow-ups: 
perinatal and at ages 1, 4, 11, 15 and 18 years. The 1-year 
and 4-year follow-ups were conducted only in a subsample 
of the original cohort. The same children were the target 
population (n=1460) for both follow-ups which consisted 
of all low birth weight children (n=510) plus a random 
sample of 20% of children who were not born with low 
birth weight (n=950). The response rates for each 
follow-up were 99.6% (n=5249), 93.4% (n=1363), 87.2% 
(n=1273), 87.5% (n=4452), 85.7% (n=4349) and 81.4% 
(n=4106), respectively (see online supplementary file 1). 
More details of each follow-up are described elsewhere.15 
A diagram with a description of the cohort follow-ups 
used in this study is available in online supplementary file 
1. Household visits were performed in every wave except 
for the 18-year-old visit which took place at the university 
research clinic where interviews, physical examinations 
and collection of biological samples were carried out.16
The protocol study was approved by the School of 
Medicine Ethics Committee of the Federal University 
of Pelotas. All participants or their legal representatives 
voluntarily signed a consent letter prior to participa-
tion in each follow-up. Verbal consent was provided in 
the perinatal phase.
Assessment of outcomes
We examined the following cardiovascular risk markers 
measured at the 18-year follow-up: CRP, total cholesterol 
(TC), HDL-cholesterol (HDL-C), LDL-cholesterol (LDL-
C), triglycerides (TGL), systolic blood pressure (SBP), 
diastolic blood pressure (DBP), BMI and WC.
Venous blood samples were collected regardless of 
fasting status, left at room temperature for 30 min and 
then centrifuged for 15 min at 2000 g. Serum aliquots 
were stored at −80°C until analysis. Blood samples were 
not taken in pregnant or suspected pregnant participants 
(n=59). Lipids were measured using an automatic enzy-
matic colorimetric method in a biochemistry analyzer 
(BS-380 Mindray; Shenzhen Mindray Bio-Medical Elec-
tronics, China). CPR was measured by turbidimetric 
immunoassay also using the BS-380 analyzer. Blood pres-
sure was recorded in the seated position using a calibrated 
digital wrist monitor (Omron HEM-629, Beijing, China). 
Measurements were taken at the start and at the end of 
the visit and the mean of the two measurements was used 
in the analysis.
Current BMI was calculated by dividing weight in kilo-
grams by height squared in metres. Weight was measured 
using a scale coupled to BodPod equipment (Life 
Measurement, Concord, California, USA) and height 
was obtained with standardised techniques using a wall–
mounted stadiometer (SECA 240; Seca, Birmingham, 
UK). Waist circumference was measured with a fibreglass 
tape at the narrowest point of the torso.17
Assessment of exposures
Birth weight and length were recorded in the mater-
nity hospitals at delivery. In the subsequent follow-ups 
the measurements were conducted at the participant’s 
home and at the research clinic in the 18-year follow-up. 
On each occasion, weight and length or height were 
measured by trained field workers using standard equip-
ment and protocols.
We studied growth patterns in several life periods: 
infancy (from birth to 1 year), early and mid-childhood 
(1–4 and 4–11 years old, respectively) and early and late 
adolescence (11–15 and 15–18 years old, respectively). 
For each age interval the separate effects of weight 
gain and linear growth were examined using CWh and 
CH proposed by Adair et al.12 CWh takes into account 
current height and preceding weights and lengths or 
heights, and CH takes into account prior weight and 
length or height measures but not current weight.12
To calculate these conditional measures we computed 
sex-specific internally derived z-scores for weight and 
length or height at each follow-up. We then regressed 
the z-score size measurements (weight or height) at a 
given age on z-scores at all previous measurements. The 
conditional measure is represented by the standardised 
residuals derived from the regression and indicates the 
deviation from the individual’s expected measures, in 
view of his or her previous growth and the average growth 
of the cohort members. This could be interpreted as a 
measure of relatively faster or slower weight or length/
height change over a period of time. For example, an 
adolescent with a positive CWh value from 11 to 15 years 
put on more weight compared with his or her previous 
weights and length/heights and weights and length/
heights of all cohort participants. As the conditional vari-
ables are uncorrelated, they can be included in a multiple 
regression model without breaking any assumption of 
collinearity.18
statistical analyses
We first described the outcomes by means (SD) (geometric 
means for asymmetric data: CRP and TGL); t-tests were 
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used to estimate mean differences between sexes. To 
assess the association between each outcome and condi-
tional growth we used linear regression and P values were 
obtained by Wald’s test. The outcomes were standardised 
to allow direct comparisons of the regression coefficients. 
We adjusted for the following confounding factors: 
family income (in minimum wages), maternal education 
(completed years of schooling) at birth, self-reported skin 
colour (white, black or others), breastfeeding (total dura-
tion of breastfeeding in months) and maternal smoking 
during pregnancy (yes/no). Unadjusted and adjusted 
coefficients and statistical significance of associations did 
not differ markedly with the inclusion of confounders in 
our models, so we presented only adjusted results. We 
included a term of interaction by sex in the model which 
provided statistical evidence of interaction in most of 
the associations, therefore analyses are shown stratified 
by sex. Analyses were performed using Stata 12.1 (Stata 
Corp, College Station, Texas, USA).
results
At a mean (SD) age of 18.5 (0.25) years, 4106 adolescents 
were evaluated. CWh and CH data across infancy, child-
hood and adolescence were available for 957 participants 
(23.4% of the 18-year-old follow-up). Our main analysis 
samples consisted of those cohort members who had 
complete data on exposures, confounders and at least 
one outcome. Therefore, our sample sizes were 917 for 
blood examinations and 946 for blood pressure, BMI and 
WC.
Mean levels of SBP and WC were higher in boys than 
in girls. On the other hand, girls had higher values of TC, 
HDL-C, LDL-C and TGL compared with boys. No differ-
ences were shown for DBP and BMI by sex (table 1).
Mean outcome values of the main analysis samples were 
compared with mean outcome values of all participants 
who had information on blood tests, blood pressure and 
anthropometric measures. Only a few differences were 
observed between both samples. Boys included in the 
main analyses had lower CPR and higher HDL-C values 
compared with boys who were evaluated at the 18-year 
follow-up. Among girls, those included in the main anal-
yses showed higher LDL-C than the total girls who were 
examined at the 18-year follow-up (see online supple-
mentary file 2). The proportions of boys and girls were 
slightly different in the two samples, with boys slightly 
under-represented in the main analysis sample compared 
with the sample comprising all participants who had 
information on blood tests, blood pressure and anthro-
pometric measures (about 47.6% vs 49.8%). Comparing 
those included in the main analysis sample with those 
excluded, we observed statistical evidence of differences 
in mean values of TGL and WC among boys (see online 
supplementary file 3).
Tables 2 and 3 show the association of size at birth, 
CWh and CH with cardiovascular risk markers at 18 years 
of age.
CRP levels showed a positive association with CWh 
during childhood and adolescence (1–4 years, 4–11 years 
and 11–15 years in both sexes and 15–18 years only in 
girls). The association between CRP and weight gain 
appeared to be stronger and with an increasing trend 
across age periods in girls. Positive associations between 
CRP and CH between 1 and 4 years were found in both 
sexes (tables 2 and 3).
Overall, the lipid profile was associated with CWh gain 
during childhood and adolescence, especially in boys. 
CWh in early childhood (1–4 years) was positively asso-
ciated only with TGL, and CWh in children aged 4–11 
years was positively associated with LDL-C and TGL and 
negatively associated with HDL-C (table 2). CWh during 
early and late adolescence (11–15 years and 15–18 years) 
was positively related with TC, LDL-C and TGL and nega-
tively related with HDL-C (table 2). In girls, HDL-C was 
inversely associated only with CWh in mid-childhood 
(4–11 years) and both early and late adolescence (11–15 
years and 15–18 years), whereas TC and LDL-C and TGL 
showed positive associations with CWh in late adoles-
cence (table 3).
Findings for SBP were similar for both sexes. However, 
DBP showed different patterns between sexes. Higher 
CWh during early and mid-childhood (1–4 years and 4–11 
Table 1 Mean (SD) outcomes at 18 years of age in the 
main analyses samples stratified by sex: 1993 Pelotas birth 
cohort*
Outcomes Boys (n=438) Girls (n=479) P value
C-reactive protein 
(mg/L)†
0.64 (3.10) 1.35 (3.92) <0.001
Total cholesterol 
(mg/dL)
151.31 (24.46) 172.29 (30.35) <0.001
HDL cholesterol 
(mg/dL)
52.78 (8.75) 59.50 (10.54) <0.001
LDL cholesterol 
(mg/dL)
83.55 (18.46) 97.14 (25.42) <0.001
Triglycerides
(mg/dL)† 
70.81 (1.46) 74.79 (1.44) 0.03
Systolic blood 
pressure
(mm Hg)‡
130.35 (11.56) 115.40 (10.04) <0.001
Diastolic blood 
pressure
(mm Hg)‡
70.54 (8.29) 69.71 (7.83) 0.12
Body mass index 
(kg/m2)‡
23.00 (4.25) 23.58 (5.05) 0.05
Waist 
circumference 
(cm)‡
77.51 (9.71) 73.74 (10.32) <0.001
Data are arithmetic mean (SD) unless otherwise indicated.
*Main analysis sample includes individuals with complete data on 
all growth measures, all confounders and at least one outcome.
†Geometric mean (SD).
‡Boys n=447; girls n=499.
HDL, high density lipoprotien; LDL, low density lipoprotein.
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years) and through early and late adolescence (11–15 
years and 15–18 years) was associated with higher SBP in 
both sexes, and with higher DBP only in girls. Regarding 
linear growth, conditional length gain during the first year 
of life and CH gain during early and mid-childhood (1–4 
years and 4–11 years) was related with increased levels 
of SBP in both sexes, whereas CH gain during early and 
mid-childhood were related with increased levels of DBP 
only in girls (tables 2 and 3). Mean arterial pressure was 
also assessed. In general, the results are consistent with 
those shown for SBP and DBP in both sexes (see online 
supplementary file 4).
CWh in all age periods was associated with higher BMI 
and WC in boys and girls, with apparently larger coef-
ficients after the first year of life (tables 2 and 3). CH 
between birth and 1 year of age was positively related 
with BMI and WC only in boys. CH throughout early and 
mid-childhood (1–4 years and 4–11 years) was positively 
related with BMI and WC in both sexes (tables 2 and 3). 
CWh was more strongly related to BMI and WC than 
linear growth. All the regression coefficients are shown 
in the original scales of outcomes (eg, mg/dL for lipid 
profile) in online supplementary file 5.
DIsCussIOn
Our results showed some differences in the relative 
contributions of weight gain and linear growth to cardio-
vascular risk. In general, we observed that greater CWh in 
childhood (1–4 years and 4–11 years) was positively asso-
ciated with CRP, LDL-C, TGL, SBP, DBP, BMI and WC 
in boys, and with CRP, DBP, SBP, BMI and WC in girls 
(inverse associations with HDL-C in both sexes). Greater 
CWh in adolescence (11–15 years and 15–18 years) was 
positively associated with CRP, TC, LDL-C, TGL, SBP, 
BMI and WC and negatively associated with HDL-C in 
both sexes, and with DBP only in girls. Also, CWh during 
the first year of life was only related to BMI and WC in 
18-year-old adolescents of both sexes. By contrast, asso-
ciations between linear growth and the cardiovascular 
markers showed a less consistent pattern when compared 
with weight gain. Greater CH in infancy was associated 
with higher values of SBP in boys and girls, and with BMI 
and WC only in boys.
Previous evidence from low-, middle- and high-income 
countries showed that excessive weight gain predicts 
subsequent metabolic and cardiovascular diseases when 
it occurs in childhood, specifically after the second year 
of life.12 13 19 Overall, our findings showing an association 
from early childhood (after the first year of age) onwards 
are consistent with this evidence. The association between 
weight gain throughout life and CRP concentrations 
in young adulthood was examined in the 1982 Pelotas 
birth cohort. In agreement with our analysis, the study 
showed that excessive weight gain at all age periods after 
the second year of life in both sexes was positively associ-
ated with CRP levels in 23-year-old participants of both 
sexes.20 We also found that excessive weight gain during 
childhood and adolescence was associated with increased 
total cholesterol, LDL-C and TGL and decreased HDL-C. 
Weight gain from birth to 4 years and lipid profile levels 
at 18 years were studied in the 1982 cohort and negative 
associations were found between excessive weight gain 
from 2 to 4 years and HDL-C, although the association 
was reduced after controlling for current BMI.21 In a 
study using data from the ALSPAC cohort in England, 
the authors observed that greater BMI in mid-childhood 
predicted higher blood pressure (SBP and DBP) in 
17-year-old adolescents.22
Fall et al assessed the relations between components 
of metabolic syndrome and weight gain at three periods 
from birth to 28 years of age when the outcomes were 
measured. In line with our findings, the study showed 
that greater weight gain in childhood (2–11 years) was 
associated with increased values of WC, SBP and TLG, 
while greater weight gain from 11 to 28 years predicted 
higher WC, TGL, total cholesterol and SBP and lower 
HDL-C. They also observed positive associations between 
rapid weight gain during the two first postnatal years and 
WC, SBP and TGL.19
In agreement with an analysis from the Vellore birth 
cohort in India,23 we observed that rapid CWh in infancy 
(birth to 1 year) was positively associated with BMI 
and WC, but not with other cardiovascular markers. A 
meta-analysis assessing infant growth and subsequent 
obesity also showed that infants who grew more rapidly 
had a higher risk of developing obesity at later ages.7 
Studies that assessed the relation between growth and 
body composition showed that rapid weight gain in 
infancy was more related with fat-free mass than with fat 
mass in adulthood.12 24 In contrast, rapid weight gain from 
childhood onwards generally is associated with accumula-
tion of greater fat mass than with fat-free mass.11 12 24–26 
These findings may explain the positive associations of 
relative weight gain at all age periods with BMI, as this 
indicator does not distinguish body fat from fat-free mass.
In relation to linear growth, we observed that faster CH 
mainly in childhood was found to be positively associated 
with blood pressure (SBP and DBP), BMI and WC at 18 
years of age in both sexes. A previous report with data 
from the same cohort examined the association between 
conditional growth at three different age ranges up to 4 
years old, BMI and blood pressure at 15 years and found 
positive associations between conditional height from 1 
to 4 years and both outcomes, although the association 
with SBP became insignificant when adjusted for BMI 
at 15 years.27 Haugaard et al found a positive association 
between linear growth during childhood and SBP and 
WC at 8 years of age.28 The previously mentioned Vellore 
birth cohort showed that rapid CH throughout the life 
course was positively associated with blood pressure and 
WC in young adults.23 It is known that blood pressure is 
higher in taller people, which may be the result of an adap-
tation of the vascular function to perfuse a longer arterial 
tree. However, inverse relations between adult height and 
cardiovascular diseases have also been described,29 which 
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suggests that this adaptation may not have pathological 
consequences.
The strengths of this study include a population-based 
sample and the availability of several anthropometric 
and biological markers of cardiovascular risk. Further-
more, our data have been collected prospectively 
since birth by trained staff with the use of standardised 
methods, reducing the susceptibility to misclassifica-
tion. We also highlight the use of conditional growth 
to examine highly correlated measurements typical of 
longitudinal studies, and the assessment of the sepa-
rate contributions of linear growth and weight gain 
relative to linear growth. Nevertheless, the assessment 
of relative weight gain does not distinguish between 
fat-free and fat mass gain.
We acknowledge some limitations of our study. First, 
our analyses were carried out only on those cohort 
participants with anthropometric data from several 
follow-ups, including subsamples. The potential 
impact of losses to follow-up on our results is difficult 
to assess. Second, we cannot rule out the possibility 
of random significant associations, as it is known that 
multiple hypothesis testing leads to increased type I 
error. Third, measurements at 2 years of age were not 
available in the 1993 Pelotas birth cohort and there-
fore we were not able to assess growth at this age 
point. The inclusion of 2 years of age in longitudinal 
studies assessing the associations between growth and 
cardiovascular risk is very important due to growing 
evidence that excessive relative weight gain denotes 
an increased risk for cardiovascular health when 
it occurs after 2 years of age. Although we do not have 
evidence of the impact of conditional growth at 2 years 
of age on later outcomes, our findings for the first year 
of life add to the evidence that improving nutrition 
during the 'first days of life’ would result in long-term 
benefits on health, as greater infant weight gain and 
linear growth during this period have more benefits 
than risks for health, particularly improvement in 
capital human outcomes such as schooling and final 
achieved height.12 13
Although we studied a particular population (ie, chil-
dren born in 1993 in the urban area of Pelotas, Brazil), 
we observed many similarities with the results of several 
studies, which suggests that our findings may be gener-
alisable to populations in other low- and middle-income 
countries.
Given that cardiovascular risk can track from adoles-
cence to adulthood,30 31 a better understanding of the 
possible adverse effects of growth patterns at earlier 
stages in life can help to develop interventions aimed 
at preventing subsequent chronic diseases. Based on 
this study and other published evidence, we conclude 
that excessive weight gain from childhood onwards may 
have an adverse effect on cardiovascular health later in 
life. This reinforces efforts to inform strategies to avoid 
children putting on weight after their first 2 years of life 
for cardiovascular prevention. Evidence regarding linear 
growth throughout birth to late adolescence and subse-
quent cardiovascular risk remains unclear and needs 
further investigation.
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